Clinical Trial Update: Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the analgesic efficacy and safety of topical VMD-3866 gel for chemotherapy-induced peripheral neuropathy, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Drug-induced Nephropathy

Drugs mentioned

• VMD-3866 Gel (VMD-3866)

Snippet

Sponsor: VM Therapeutics LLC | Conditions: Chemotherapy-induced Peripheral Neuropathy, Drug-Induced Nephropathy | Phase 2 | Status: RECRUITING